HC Wainwright Has Bearish Forecast for DAWN FY2028 Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Investment analysts at HC Wainwright cut their FY2028 earnings per share estimates for Day One Biopharmaceuticals in a research report issued on Wednesday, May 7th. HC Wainwright analyst A. Maldonado now expects that the company will post earnings of $0.74 per share for the year, down […]
